Pharma Logistics Insight
Pharma-validated multi-chamber logistics equipment ensures reliable multi-temperature shipments, compliance, sustainability, efficiency, and patient safety.
Langham’s
Langham’s new website delivers a modern, mobile-friendly design with faster access to services, resources, and news.
Dear Clients and Partners,
At Langham Logistics, our mission is to help you move life-changing products with certainty and care. As 2025 progresses, we are sharpening our focus on three areas shaping the future of pharma logistics: advancing cold chain security, delivering precision in clinical trial transportation, and leading the way in Controlled Room Temperature (CRT) services.
We are also proud to celebrate milestones that reflect both innovation and growth. This includes recognition among Indiana’s most influential business leaders and the launch of our redesigned website — built to give you faster, easier access to resources, insights, and tools that help you succeed.
Whether it’s safeguarding sensitive shipments with pharma-validated multi-chamber equipment, supporting clinical trial logistics, or providing the stability of validated CRT environments, we remain committed to earning your trust every day.
Thank you for making us part of your mission. Together, we’re moving the future of healthcare forward.
With appreciation,
Cathy Langham Chief Executive Officer Langham Logistics
Global pharmaceutical logistics requires solutions that adapt to diverse product requirements. Langham’s pharma-validated multi-chamber equipment offers precise, separate temperature zones within the same shipment — protecting sensitive cargo, optimizing load capacity, and improving efficiency.
Pharma - validated multi - chamberequipment allows shippers to move products with varying temperature requirements in a single dedicated load. For example, one chamber can maintain a frozen environment at –20°C, while another holds refrigerated products at +2°C to +8°C or controlled room temperature (CRT) conditions.
This capability reduces the need for multiple trips while still keeping customer shipments point - to - point and separate. It also minimizes handling and limits the risk of temperature excursions.
Every piece of multi - chamber equipment is rigorously validated to meet GDP, cGMP, and FDA standards. Validation data provides documented assurance that temperature ranges are consistently maintained, even during unexpected weather or route delays. This level of proof helps pharmaceutical shippers remain confident in their compliance and audit readiness.
Temperature excursions are one of the most significant risks in cold chain logistics. Pharma - validated multi - chamber systems are engineered and tested to deliver
reliable, repeatable performance. Each unit is validated to ensure it maintains strict temperature ranges under challenging transit conditions.
This proven performance safeguards product quality, protects patient safety, and ensures regulatory compliance every step of the way.
Multi - chamber equipment allows shippers to maximize trailer capacity without mixing unrelated customers’ goods. By managing multiple temperature profiles in a single dedicated shipment, companies reduce fuel consumption and minimize the number of trips required. This approach supports ESG goals and helps lower overall transportation costs.
Pharma - validated multi - chamber equipment gives pharmaceutical companies a smarter way to move sensitive materials. But equipment alone is not enough. Langham’s trained subject matter experts oversee every shipment, interpret data in real time, and act quickly to maintain compliance and customer quality agreements.
Cathy Langham Recognized as a 2025 Indiana Living Legend & Indiana 250 Honoree
Cathy Langham, co-founder and CEO of Langham Logistics, has been named a 2025 Indiana Living Legend by the Indiana Historical Society. She joins an esteemed class of four honorees: Michael Browning, Greg Gibson, and Myra Selby, recognized for their extraordinary contributions to business, civic life, and community leadership. The black-tie gala will take place on August 15, 2025, at the Eugene and Marilyn Glick Indiana History Center in Indianapolis.
The Living Legends program is the Historical Society’s signature fundraising event, designed to support statewide programs that collect and preserve Indiana’s unique stories. Honorees are chosen by a committee of civic and corporate leaders for sustained
achievement and service. For Cathy, this recognition underscores a career defined by innovation, resilience, and the ability to grow a family-founded logistics business into a trusted partner for the world’s most highly regulated industries.
Under Cathy’s leadership, Langham Logistics has become a $100+ million enterprise specializing in pharmaceutical and life sciences supply chains. With validated CRT facilities, GMP-compliant warehouses, and a growing cold chain footprint, Langham continues to expand its national reach while keeping its headquarters and roots firmly in Indiana. Cathy’s service on high-profile boards, including Penske Entertainment and Indiana University, reflects her broader influence on business and civic life in the state.
In addition to being named a Living Legend, Cathy was also honored as one of the 2025 Indiana 250. This recognition highlights the state’s most influential business leaders across industries and acknowledges her ongoing contributions to Indiana’s economic growth. The Indiana 250 list is compiled annually and celebrates executives who are shaping the future of business through leadership, strategy, and vision.
For Langham’s clients, these dual recognitions serve as more than accolades. They represent the qualities that guide the company’s operations every day: foresight, compliance, accountability, and a people-first approach. Cathy’s leadership ensures that Langham Logistics remains not just a logistics
provider but a strategic partner capable of helping pharmaceutical and life sciences companies navigate complexity with confidence. Together, these honors affirm Cathy Langham’s place among Indiana’s most respected leaders. They highlight a career built on service to clients, dedication to community, and the vision to build an organization that continues to expand its impact well beyond state lines.
Controlled Room Temperature (CRT) storage may not demand ultra-cold conditions, but in today’s pharmaceutical supply chain, it is just as critical for product safety, regulatory compliance, and patient well-being. At Langham Logistics, CRT is more than just space — it’s a validated, monitored, and security-driven solution built to scale with the growing needs of life sciences clients.
Langham’s CRT facilities are fully validated to meet 21 CFR Part 11, FDA, cGMP, and GDP requirements. This means every controlled environment operates within the industry’s most rigorous compliance frameworks, ensuring that products ranging from oral solid doses to highvolume therapies retain their stability and efficacy. Each unit is temperature-mapped, continuously monitored, and designed to exceed audit expectations.
Langham has strategically expanded its CRT footprint to align with growing demand. Facilities in Indiana, Arizona, and Pennsylvania give clients access to regional hubs designed to support both clinical trial materials and commercial-scale distribution. The Easton, PA GMP facility alone adds 225,000 square feet of capacity, including 25,000 pallet positions of validated CRT storage. This expansion provides scalability for fast-growing therapies such as biologics, oncology treatments, and specialty drugs that require strict CRT conditions.
Compliance and capacity are only part of the equation. Langham integrates security directly into its CRT operations with biometric access, surveillance systems, and documented chain of custody. Every shipment moving into or out of a CRT facility is tracked, logged, and validated, reducing risk and ensuring accountability from dock to delivery.
In addition, Langham aligns its operations with TAPA and C-TPAT standards, ensuring that supply chain security is not an afterthought but a core part of CRT service. This layered approach gives clients confidence that their products are safeguarded not just against temperature deviation but also theft, tampering, or data compromise.
Langham’s proprietary Transportation Management System (TMS) integrates CRT data into a central platform, giving clients real-time visibility into product conditions, shipment status, and compliance documentation. This level of transparency is invaluable for pharmaceutical companies navigating strict quality agreements, FDA inspections, and client-driven audits. By combining automation with expert oversight, Langham ensures that clients can not only store but also prove the stability and safety of their CRT-handled products.
As pharmaceutical pipelines expand — from traditional small molecules to advanced biologics and therapies — demand for CRT storage will only increase. Langham is meeting this challenge with a forward-looking CRT strategy: scalable facilities, validated processes, and continuous investment in compliance and technology.
For clients, CRT is not just about meeting today’s needs. It’s about preparing for tomorrow’s growth and ensuring patient outcomes are never compromised.
As the pharmaceutical industry evolves, the need for robust Controlled Room Temperature (CRT) storage has surged. While ultra-cold environments often dominate the spotlight, CRT is the backbone of everyday pharmaceutical logistics, supporting the safe distribution of high-volume therapies ranging from oral solids to biologics. Langham Logistics has recognized this demand and strategically expanded its CRT footprint to give clients the scale, stability, and compliance they need.
reputation as a trusted partner for highvalue, high-risk cargo. This layered security model protects against theft, tampering, or environmental excursions — key concerns for manufacturers, regulators, and ultimately, patients.
Langham’s proprietary Transportation Management System (TMS) integrates facility monitoring with client-facing portals, enabling real-time visibility into storage conditions and inventory levels. Automated reporting tools generate audit-ready documentation, streamlining compliance for clients while reducing administrative burden.
By combining automation with a quality-first culture, Langham ensures that data integrity and operational performance move hand in hand.
Combined with facilities in Indiana and Arizona, Easton gives clients a broader network of regional distribution hubs, improving access to population centers, clinical trial sites, and manufacturing partners. For growing therapies in oncology, autoimmune disorders, and specialty care, this scalable CRT infrastructure ensures product availability without compromising quality.
The opening of Langham’s 225,000-squarefoot GMP-compliant facility in Easton, Pennsylvania marks a major milestone in the company’s national expansion strategy. This site alone adds over 25,000 pallet positions of validated CRT storage, strengthening Langham’s capacity in one of the nation’s most important life sciences corridors.
Langham’s CRT environments are designed from the ground up to meet strict global standards, including GDP, FDA, and 21 CFR Part 11 compliance. Each CRT zone is temperature-mapped, continuously monitored, and backed by digital audit
trails. This level of validation ensures that pharmaceutical products maintain stability throughout storage and can withstand the scrutiny of regulatory inspections.
For clients, these environments provide peace of mind: every pallet, every shipment, every record is maintained to the highest standards of compliance and documentation.
Security in CRT logistics extends beyond locked doors. Langham’s facilities integrate biometric access controls, high-resolution surveillance, environmental alarms, and chain-of-custody documentation. Every handoff is tracked and logged, ensuring transparency from dock to delivery.
Langham also aligns its operations with leading industry security frameworks, including TAPA and C-TPAT, reinforcing its
The demand for CRT storage is expected to continue rising over the next decade as pipelines expand for biologics, cell and gene therapies, and high-volume treatments like GLP-1s for obesity. Langham’s proactive investment in facilities like Easton positions the company — and its clients — for longterm success in a dynamic and highly regulated marketplace.
For life sciences companies, partnering with Langham means more than gaining space on a shelf. It means securing a partner who can scale with growth, protect critical inventory, and meet the evolving demands of regulators and patients alike.
Langham’s redesigned website offers a more intuitive, mobile-friendly experience, giving clients faster access to news, resources, and service information — all in a streamlined, modern format.
In the pharmaceutical industry, logistics is not just about moving products. It is about protecting patient outcomes, ensuring compliance, and building supply chain strategies that anticipate tomorrow’s challenges. Langham Logistics has built its reputation as a trusted partner in life sciences by combining validated infrastructure, specialized expertise, and a people-first culture to deliver solutions that truly move medicine forward.
Langham’s pharmaceutical and life sciences facilities are purpose-built to meet the most rigorous standards, including FDA, GDP, cGMP, and 21 CFR Part 11 compliance. From controlled room temperature (CRT) storage to ultra-low-temperature environments, every square foot is designed with validation, audit-readiness, and security in mind.
The company’s recent expansion, a 225,000-square-foot GMP-compliant facility in Easton, Pennsylvania, adds 25,000 pallet positions of CRT storage alongside refrigerated and frozen capacity. This investment reflects the growing demand for safe, compliant environments that can scale with evolving therapies such as biologics, oncology treatments, and specialty pharmaceuticals. For Langham
clients, it means reliable access to space, systems, and service that meet the highest global standards.
Temperature-sensitive products require more than just storage. They require real-time visibility, precision monitoring, and processes designed to respond before deviations occur. Langham’s cold chain and CRT solutions include:
• Continuous monitoring with automated alerts and escalation protocols.
• Temperature mapping and documentation to meet audit requirements.
• Chain-of-custody records that give clients confidence in product integrity.
• Redundant systems to ensure uninterrupted compliance.
By pairing technology with trained staff, Langham protects therapies at every stage of the supply chain, from clinical trial kits to global product launches.
Clinical trials represent some of the most complex, time-sensitive, and regulated logistics challenges. Langham provides the expertise to ensure investigational products, patient kits, and ancillary supplies arrive safely and on schedule. With validated CRT and cold chain facilities, specialized packaging solutions, and strict quality agreements, Langham helps clients accelerate trials without compromising compliance or patient safety.
By aligning clinical trial logistics with commercial-scale infrastructure, Langham provides a seamless bridge as therapies move from research to market.
Pharmaceutical logistics demands more than operational efficiency. It requires unwavering attention to compliance and security. Langham integrates these values into every aspect of its operations:
• Biometric facility access and 24/7 surveillance ensure physical security.
• TAPA- and C-TPAT-aligned procedures mitigate risks in transit.
• Audit-ready documentation is embedded in processes, supported by electronic records that meet FDA requirements.
This layered approach means clients can rely on Langham not only for operational excellence but also for assurance that their products are safeguarded against both environmental and security risks.
Langham’s proprietary Transportation Management System (TMS) integrates shipment tracking, facility monitoring, and client-facing reporting. Clients gain real-time visibility into product conditions, inventory levels, and performance metrics. Automated reporting simplifies audits while freeing teams to focus on strategic initiatives.
Technology at Langham is not about replacing people. It is about empowering them with better tools to serve clients.
Moving Medicine Forward Together
At its core, Langham’s mission is about impact. Every shipment represents more than cargo. It represents therapies for patients, breakthroughs in research, and the potential to improve or save lives. By investing in infrastructure, compliance, and people, Langham delivers solutions that keep supply chains strong, resilient, and ready for what is next.
For pharmaceutical and life sciences partners, this means more than logistics. It means having a partner committed to innovation, accountability, and care at every step.
Solutions That Move Medicine Forward is not just a tagline. It is a promise that Langham fulfills every day, for every client, and for every patient who depends on the safe, reliable movement of medicine.
